A Two-Part Study to Assess the Safety, Tolerability and Pharmacokinetics of Single and Multiple Ascending Subcutaneous Doses of TCMCB07 on Healthy Male and Female Subjects

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 27 Feb 2024

Price :

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

19 Feb 2024 Status changed from recruiting to completed.
06 Jun 2023 Preliminary results presented at the 59th Annual Meeting of the American Society of Clinical Oncology.
19 Jan 2023 According to an Endevica Bio media release, company look forward to the release of results from the Multiple Ascending Dose (MAD) arm of this study that was completed the end of December 2022.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com